Cargando…

Study protocol of the randomised placebo-controlled GLOBE trial: GLP-1 for bridging of hyperglycaemia during cardiac surgery

INTRODUCTION: Perioperative hyperglycaemia is common during cardiac surgery and associated with postoperative complications. Although intensive insulin therapy for glycaemic control can reduce complications, it carries the risk of hypoglycaemia. GLP-1 therapy has the potential to lower glucose witho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulst, Abraham H, Visscher, Maarten J, Godfried, Marc B, Thiel, Bram, Gerritse, Bas M, Scohy, Thierry V, Bouwman, R Arthur, Willemsen, Mark G A, Hollmann, Markus W, DeVries, J Hans, Preckel, Benedikt, Hermanides, Jeroen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988155/ https://www.ncbi.nlm.nih.gov/pubmed/29866735 http://dx.doi.org/10.1136/bmjopen-2018-022189

Ejemplares similares

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial
por: Hulst, Abraham H., et al.
Publicado: (2019)

Effects of Liraglutide on Myocardial Function After Cardiac Surgery: A Secondary Analysis of the Randomised Controlled GLOBE Trial
por: Hulst, Abraham H., et al.
Publicado: (2020)

Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes–PILGRIM trial
por: Polderman, Jorinde AW, et al.
Publicado: (2014)

Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons
por: Hermanides, Jeroen, et al.
Publicado: (2011)

Systematic review of incretin therapy during peri-operative and intensive care
por: Hulst, Abraham H, et al.
Publicado: (2018)

Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
por: Li, Xiaoling, et al.
Publicado: (2021)

The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes
por: Levy, Brian L, et al.
Publicado: (2016)

Early Recognition of Overweight Hyperglycaemia May Improve Clinical Outcomes in Type 2 Diabetes
por: Chockalingam, Anand, et al.
Publicado: (2023)

Outcomes of hyperglycaemia in pregnancy in Africa: systematic review study protocol
por: Musa, Ezekiel, et al.
Publicado: (2021)

The prevalence of cardiovascular autonomic neuropathy and its influence on post induction hemodynamic variables in patients with and without diabetes; A prospective cohort study
por: Polderman, Jorinde A. W., et al.
Publicado: (2018)

Diabetes and intermediate hyperglycaemia in Kisantu, DR Congo: a cross-sectional prevalence study
por: Muyer, Muel Telo, et al.
Publicado: (2012)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond – New Insights 2015
por: Gallwitz, Baptist
Publicado: (2015)

Effect of hyperglycaemia in pregnancy on adiposity in their infants in India: a protocol of a multicentre cohort study
por: Babu, Giridhara R, et al.
Publicado: (2014)

Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
por: Weenink, Robert P., et al.
Publicado: (2020)

Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults
por: Liu, Yan, et al.
Publicado: (2015)

Accuracy and Reliability of Continuous Glucose Monitoring in the Intensive Care Unit: A Head-to-Head Comparison of Two Subcutaneous Glucose Sensors in Cardiac Surgery Patients
por: Siegelaar, Sarah E., et al.
Publicado: (2011)

Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes
por: Kaneko, Shizuka
Publicado: (2022)

GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
por: Donath, Marc Y., et al.
Publicado: (2013)

The Role of GIP in the Regulation of GLP-1 Satiety and Nausea
por: Hayes, Matthew R., et al.
Publicado: (2021)

Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
por: Preckel, Benedikt, et al.
Publicado: (2020)

Do GLP-1–Based Therapies Increase Cancer Risk?
por: Nauck, Michael A., et al.
Publicado: (2013)

A cross-sectional study of glucose regulation in young adults with very low birth weight: impact of male gender on hyperglycaemia
por: Sato, Ryosuke, et al.
Publicado: (2012)

Does Regular Practice with a “Flexible Bronchoscopy Simulator” Improve Fibreoptic Intubation Skills in Experts and Novices? A Randomized Controlled Study
por: van Haperen, Maartje, et al.
Publicado: (2023)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

Personalising activity to target peak hyperglycaemia and improve cardiometabolic health in people with type 2 diabetes: protocol for a randomised controlled trial
por: Chang, Courtney R, et al.
Publicado: (2022)

Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
por: Tatalovic, Milos, et al.
Publicado: (2019)

Ability of verbal autopsy data to detect deaths due to uncontrolled hyperglycaemia: testing existing methods and development and validation of a novel weighted score
por: Blackstock, Sarah, et al.
Publicado: (2019)

Sense and nonsense in sensors
por: Hermanides, J., et al.
Publicado: (2010)

Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
por: Ludwig, Mette Q., et al.
Publicado: (2021)

Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis
por: Chen, Min, et al.
Publicado: (2016)

Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
por: Li, Xiaoling, et al.
Publicado: (2021)

Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway
por: Tigchelaar, Celien, et al.
Publicado: (2022)

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
por: Uthman, Laween, et al.
Publicado: (2020)

THU264 Enteric Activity Enhanced Ileal GLP-1 Secretion
por: Chen, Yixin, et al.
Publicado: (2023)

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink
por: Gamble, John-Michael, et al.
Publicado: (2018)

THU263 Intestinal Production of H(2)S And Its Regulation Of GLP-2
por: Hammond, Joel, et al.
Publicado: (2023)

Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China
por: Zhang, Fang, et al.
Publicado: (2018)

FRI657 Case Series On GLP-1 Receptor Agonist Related Acute Pancreatitis
por: Kumar Kulkarni, Abhigna Uday, et al.
Publicado: (2023)

THU334 Trends In GLP-1 Agonist Utilization In Diabetics With And Without Vascular Disease
por: Sargin, Pinar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92c2ni1s3rcscdu9vcfqhnln1u